Clinical Trial Update: A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating SR604 for safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy participants and in patients with Hemophilia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Factor Vii Deficiency
• Hemophilia

Drugs mentioned

• SR604

Snippet

Sponsor: Equilibra Bioscience LLC | Conditions: Healthy Participants, Hemophilia A | Phase 1 | Status: RECRUITING